Therapeutic Workshop Details
Infectious Disease: Hepatitis C - Where Are We Really Going with Future Treatment Paradigms?
Wednesday, October 10, 2007
9:10 AM
Sea Cliff
HCV infects 170 million people worldwide; in the most common genotype, 48 weeks of standard therapy cures only 50% of patients. This panel will address the unmet medical need in HCV therapy and the potential that direct antivirals and next-generation interferons have in improving the efficacy and tolerability of treatment.
Moderators
- Jay S. Markowitz, MD; Vice President, Investment Analyst, T. Rowe Price
Panelists
- Mitchell Shiffman, MD; Chief, Hepatology Section, Medical Director, Liver Transplant Program, Virginia Commonwealth University Medical Center
- John J. Alam, MD; Executive Vice President, Medicines Development and Chief Medical Officer, Vertex Pharmaceuticals Incorporated
- Lawrence Blatt, PhD; Chief Science Officer, InterMune, Inc.
- M. Michelle Berrey, MD; Vice President, Clinical Development and Chief Medical Officer, Pharmasset, Inc.
- Craig Gibbs, PhD; Vice President of Commercial Strategy, Gilead Sciences, Inc.
- David C. Stump, MD; Executive Vice President, Research and Development, Human Genome Sciences, Inc.
Who's Who
Jay S. Markowitz is a vice president of T. Rowe Price Group, Inc., and T. Rowe Price Associates, Inc. He is a research analyst in the Equity Division, covering the biotechnology sector of the health care industry. Dr. Markowitz is an Investment Advisory Committee member of the Health Sciences Fund, Small-Cap Stock Fund, New Horizons Fund, and Institutional Large Cap Growth Fund. Prior to joining T. Rowe Price in 2002, he was a transplant surgeon and assistant professor of surgery at the Johns Hopkins University School of Medicine. Dr. Markowitz was a surgical resident at the Massachusetts General Hospital, a research fellow at the Harvard School of Public Health, and a transplant surgery fellow at the UCLA Medical Center. He earned a BA in chemistry, summa cum laude, from Columbia University, and an MD from Duke University.